Therapeutic and Clinical Nursing Values of Momordica charantia Extracts Combined with Hedyotis diffusa on Lung Cancer

Abstract

The separation and identification of bioactive substances that come from natural resources have aroused increasing attention. Momordica charantia ( M. charantia ) has a variety of bio-activities, containing anti-oxidation, immune regulation, anti-tumor, radiation protection, anti-diabetes, and liver protection. After the extraction new substances from Momordica charantia , their treatment effect on lung cancer combined with Hedyotis diffusa was determined and the related mechanism was explored as well in this study. Firstly, the CCK-8 assay was conducted and the inhibition of the new substances combined with Hedyotis diffusa. Next, the real time RT-PCR was conducted and the relative expression of the VEGF in the cancer cells was determined. In addition, the complete chloroplast genome sequence of M. charantia is followed by the phylogenetic analysis.